Vera Therapeutics VERA EBIT

EBIT at other companies

Vertex PharmaceuticalsVRTX

$1.25B+8.3%

Travere Therapeutics, Inc.TVTX

-$36.92M+13.5%

Aurinia PharmaceuticalsAUPH

$46.34M+131%

Climb Bio, Inc.CLYM

-$15.21M+33.9%

Jade BiosciencesJBIO

-$43.45M-85.8%

Viridian Therapeutics, Inc.VRDN

-$126.27M-18.3%

FAQ

What is Vera Therapeutics's EBIT?

Vera Therapeutics (VERA) reported EBIT of -$125.13M in Q1 2026.

How has Vera Therapeutics's EBIT changed year-over-year?

Vera Therapeutics's EBIT decreased by 118.8% year-over-year, from -$57.19M to -$125.13M.

What is the long-term trend for Vera Therapeutics's EBIT?

Over 4 years (2021 to 2025), Vera Therapeutics's EBIT has grown at a 74.0% compound annual growth rate (CAGR), from -$34.4M to -$315.47M.

What does EBIT mean?

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.